Atlas Venture Life Science Advisors Llc

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Third Harmonic Bio, Inc.
THRD
$102.97M26.6410.91M0%+$09.83
Vigil Neuroscience, Inc.
VIGL
$19.9M15.535.84M0%+$01.9
Generation Bio Co.
GBIO
$33.7M12.458.28M0%+$03.22
Korro Bio, Inc.
KRRO
$100.74M12.071.12M0%+$09.61
Ikena Oncology, Inc.
IKNA
$7.13M10.45.02M0%+$00.68
AVROBIO, Inc.
AVRO
$5.81M10.124.54M0%+$00.56
Disc Medicine, Inc.
IRON
$142.4M9.252.29M-10.49%-$16.68M13.59
Kymera Therapeutics, Inc.
KYMR
$216.17M8.765.38M-8.21%-$19.33M20.63
Dyne Therapeutics, Inc.
DYN
$227.69M8.228.02M-18.87%-$52.96M21.73
Day One Biopharmaceuticals, Inc.
DAWN
$106.23M7.366.43M-15.48%-$19.46M10.14
Aerovate Therapeutics, Inc.
AVTE
$60.3M7.082.04M0%+$05.75
Replimune Group, Inc.
REPL
$17.14M3.422.1M0%+$01.64
Xilio Therapeutics, Inc.
XLO
$1.07M2.69992,912-64.02%-$1.91M0.1
Spero Therapeutics, Inc.
SPRO
$1.05M1.13607,613-40.04%-$698,018.760.1
Dianthus Therapeutics, Inc.
DNTH
$5.61M0.64186,979-21.1%-$1.5M0.54